The challenge: There are very few ways to slow down Alzheimer’s disease or treat its symptoms, and there’s no cure — in 2021, nearly 120,000 Americans died from Alzheimer’s complications, making it one of the top 10 leading causes of death.
One genetic variant in particular — called APOE-e4 — is strongly tied to the brain disease. Having one copy makes a person 2–3 times more likely to develop Alzheimer’s, while having two copies (one from each parent) increases the risk by 8–12 times.
Rohit Singla, an MD/PhD student, shares how his training in both medicine and engineering is allowing him to identify complex problems, understand the nuances within them and tackle those complex problems with elegant solutions that are the right fit for patients with kidney disease. Using data from over 10,000 cases, he is creating artificial intelligence tools to automatically detect microscopic changes in the kidney structure and develop new treatments to improve people’s lives.
Produced by UBC faculty of medicine development and alumni engagement.
Written and produced by Yale Neuroscience PhD student Clara Liao.
Addiction is now understood to be a brain disease. Whether it’s alcohol, prescription pain pills, nicotine, gambling, or something else, overcoming an addiction isn’t as simple as just stopping or exercising greater control over impulses. That’s because addiction develops when the pleasure circuits in the brain get overwhelmed, in a way that can become chronic and sometimes even permanent. This is what’s at play when you hear about reward “systems” or “pathways” and the role of dopamine when it comes to addiction. But what does any of that really mean? One of the most primitive parts of the brain, the reward system, developed as a way to reinforce behaviors we need to survive—such as eating. When we eat foods, the reward pathways activate a chemical called dopamine, which, in turn, releases a jolt of satisfaction. This encourages you to eat again in the future. When a person develops an addiction to a substance, it’s because the brain has started to change. This happens because addictive substances trigger an outsized response when they reach the brain. Instead of a simple, pleasurable surge of dopamine, many drugs of abuse—such as opioids, cocaine, or nicotine—cause dopamine to flood the reward pathway, 10 times more than a natural reward. The brain remembers this surge and associates it with the addictive substance. However, with chronic use of the substance, over time the brain’s circuits adapt and become less sensitive to dopamine. Achieving that pleasurable sensation becomes increasingly important, but at the same time, you build tolerance and need more and more of that substance to generate the level of high you crave. Addiction can also cause problems with focus, memory, and learning, not to mention decision-making and judgement. Seeking drugs, therefore, is driven by habit—and not conscious, rational decisions. Unfortunately, the belief that people with addictions are simply making bad choices pervades. Furthermore, the use of stigmatizing language, such as “junkie” and “addict” and getting “clean,” often creates barriers when it comes to accessing treatment. There’s also stigma that surrounds treatment methods, creating additional challenges. Though treatment modalities differ based on an individual’s history and the particular addiction he or she has developed, medications can make all the difference. “A lot of people think that the goal of treatment for opioid use disorder, for example, is not taking any medication at all,” says David A. Fiellin, MD, a Yale Medicine primary care and addiction medicine specialist. “Research shows that medication-based treatments are the most effective treatment. Opioid use disorder is a medical condition just like depression, diabetes or hypertension, and as with those conditions, it is most effectively treated with a combination of medication and counseling.”
Two-photon polymerization is a potential method for nanofabrication to integrate nanomaterials based on femtosecond laser-based methods. Challenges in the field of 3D nanoprinting include slow layer-by-layer printing and limited material options as a result of laser-matter interactions.
In a new report now on Science Advances, Chenqi Yi and a team of scientists in Technology Sciences, Medicine, and Industrial Engineering at the Wuhan University China and the Purdue University U.S., showed a new 3D nanoprinting approach known as free-space nanoprinting by using an optical force brush.
This concept allowed them to develop precise and spatial writing paths beyond optical limits to form 4D functional structures. The method facilitated the rapid aggregation and solidification of radicals to facilitate polymerization with increased sensitivity to laser energy, to provide high accuracy, free-space painting much like Chinese brush painting on paper.
Generative AI for medical imaging can create infinite synthetic images of the human anatomy. These large, synthetic datasets are used for training generalizable AI models that can learn from evolving patient data while preserving patient privacy. Learn how MONAI, a framework for building and deploying medical AI, and partners like King’s College London, Mount Sinai, and East River Imaging are using generative AI to study disease and make AI decisions and predictions more accurate, trusted, and safe.
This video is about How ChatGPT/ AI can disrupt healthcare.
ChatGPT is an AI-powered chat platform developed by OpenAI. It allows users to ask questions in a conversational format and build on previous conversations, which allows for improved learning over time. Microsoft has invested billions of dollars in ChatGPT, integrating it into their search engine Bing and web browser Edge. Although the rise of AI has caused concern over job security, ChatGPT currently requires human input to generate questions and diagnose patients, making it a tool to augment human abilities in healthcare. The technology can be used for diagnosis, research, medical education, and radiographs. It can assist healthcare professionals in diagnosing and researching diseases, visualizing anatomy and procedures, and analyzing medical images.
Hello, i am back! Blood, sweat and tears have been shed these past months of absence. But enough sweating was done during the summer, tears have already been shed, so that just leaves me with blood. And whether taking a part of blood (plasma) and injecting it into old animals is enough for rejuvenation. That’s right, many of you may remember, earlier this year i made a video on the oldest living rat.- and now we have some updates: in particular, (i) what actually were the rats given, and (ii) what changes were seen, showing both some DNAm and glycan age data.
A new public database built from the ground up by Washington State University undergraduates looks to expedite scientific understanding of how skin heals.
The website — skinregeneration.org — was created for researchers but allows anyone to cross-compare information on more than 33,000 genes from different species as they relate to skin development, wound repair, and regeneration. Ultimately, it could help scientists reprogram adult skin for regeneration during wound healing and to inhibit the aging process.
“Historically, one of the major mechanisms scientists communicated through was with physical papers published in journals. A new concept of how to output knowledge is to create webtools in association with online manuscripts. For example, webtools that allow for interacting with large genomic datasets that have so much knowledge that cannot fit into a single paper. You can just interact with the data on any device and at any time you want,” said Ryan Driskell, head of WSU’s Fibroblast and Skin Regeneration Laboratory.
Aug 29 (Reuters) — Britain’s state-run national health service will be the first in the world to offer an injection that treats cancer to hundreds of patients in England which could cut treatment times by up to three quarters.
Following approval from the Medicines and Healthcare products Regulatory Agency (MHRA), NHS England said on Tuesday hundreds of eligible patients treated with the immunotherapy, atezolizumab, were set to have “under the skin” injection, which will free up more time for cancer teams.
“This approval will not only allow us to deliver convenient and faster care for our patients, but will enable our teams to treat more patients throughout the day,” Dr Alexander Martin, a consultant oncologist at West Suffolk NHS Foundation Trust said.